Dose-volume factors contributing to the incidence of radiation pneumonitis in non-small-cell lung cancer patients treated with three-dimensional conformal radiation therapy
- 1 October 2002
- journal article
- Published by Elsevier BV in International Journal of Radiation Oncology*Biology*Physics
- Vol. 54 (2), 329-339
- https://doi.org/10.1016/s0360-3016(02)02929-2
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Radiation-induced pulmonary toxicity: a dose-volume histogram analysis in 201 patients with lung cancerInternational Journal of Radiation Oncology*Biology*Physics, 2001
- Clinical dose–volume histogram analysis for pneumonitis after 3D treatment for non-small cell lung cancer (NSCLC)International Journal of Radiation Oncology*Biology*Physics, 1999
- Radiation pneumonitis as a function of mean lung dose: an analysis of pooled data of 540 patientsInternational Journal of Radiation Oncology*Biology*Physics, 1998
- Evaluation of two dose–volume histogram reduction models for the prediction of radiation pneumonitisRadiotherapy and Oncology, 1998
- Promising survival with three-dimensional conformal radiation therapy for non-small cell lung cancerRadiotherapy and Oncology, 1997
- Dose escalation for non-small cell lung cancer using conformal radiation therapyInternational Journal of Radiation Oncology*Biology*Physics, 1997
- Three-dimensional conformal radiation therapy in bronchogenic carcinomaSeminars in Radiation Oncology, 1996
- Estimation of pneumonitis risk in three-dimensional treatment planning using dose-volume histogram analysisInternational Journal of Radiation Oncology*Biology*Physics, 1995
- Dose-volume histogram and 3-D treatment planning evaluation of patients with pneumonitisInternational Journal of Radiation Oncology*Biology*Physics, 1994
- Tolerance of normal tissue to therapeutic irradiationInternational Journal of Radiation Oncology*Biology*Physics, 1991